Many observations provided strong evidence involving inflammation in the progression of chronic HF. In particular, high circulating levels of proinflammatory mediators (ie, tumor necrosis factor-α and interleukin [IL]-6) correlated with deterioration of cardiac function in patients with HF. 4 The importance of these cytokines was further supported by their biological effects on cardiac contractility and remodeling, which may explain several aspects of the HF syndrome. 5 Recently, the percentage of circulating CD4 + T cells expressing inflammatory cytokines was positively correlated with left ventricular dysfunction in patients with HF. 6,7 However, the significance of these observations and the contribution of T cells to cardiovascular remodeling are still poorly understood.
H eart failure (HF) is a complex syndrome that results from acute injury such as myocardial infarction or more long-standing diseases such as pressure and volume overload. In the case of pressure-overload conditions occurring in aortic stenosis or hypertension, cardiac remodeling evolves progressively from an initial compensatory ventricular hypertrophy to decompensated hypertrophy characterized by cardiac dilation and contractile dysfunction. 1 Loss of cardiac function is generally associated with fetal gene reprogramming, aberrant calcium handling, loss of cardiomyocytes, and excessive fibrosis. 2, 3 To date, the mechanisms responsible for the progression of cardiac remodeling and for triggering the transition from cardiac hypertrophy to failure remain unknown.
CD4 + T-cell responses. 10 The adoptive transfer of purified T lymphocytes from mice with active myocarditis was sufficient to promote the disease into recipient mice, 11, 12 underlying the importance of these cells in cardiac dysfunction.
More recently, several lines of evidence have involved T lymphocytes in cardiac remodeling after myocardial infarction. Indeed, reports have shown that modulation of immune cell response by ablation of T cells or DCs altered the initial postinfarction healing and remodeling response. By promoting the formation of mature collagen matrix and fibrosis, these immune cells may facilitate early wound healing and improved survival after myocardial infarction. 13, 14 Although immunity may contribute to different hallmarks of HF development, participation of T cells in chronic cardiac remodeling has been poorly addressed in the literature. In the present study, we used complementary mouse models to investigate the role of T lymphocytes in HF progression. Our results showed the key role of CD4 + T cells in ventricular remodeling and the progression from compensated cardiac hypertrophy to HF.
Methods
Detailed methodology is provided in the online-only Data Supplement.
Animals
Wild-type (WT) C57BL/6 mice were obtained from Janvier (Saint Berthevin, France). Mice deficient for recombination activating gene 2 expression (RAG2KO) and mice deficient for MHCII expression (MHCIIKO) as a result of a disruption of the IAβ gene in C57BL/6 were kindly provided by Dr J.P. van Meerwijk. 15 Mice deficient for CD8α (CD8KO) and mice with transgenic CD4 + T-cell receptor (TCR) specific for ovalbumin (OT-II) mice were from Charles River Laboratories. Twelve-week-old male mice were used in all the experiments and were maintained under specific pathogen-free conditions. In vivo studies were conducted in mice under European laws on the protection of animals (86/609/EEC). Mouse experiments were approved by and performed according to the guidelines of the Ethics and Animal Safety Committee of INSERM Toulouse/ENVT (agreement C3155507).
Statistics
All results are presented as mean±SEM. Two-group comparisons were analyzed by unpaired 2-tailed t tests. In the case of nonnormality, the nonparametric test 2-tailed Mann-Whitney U test was used. Multiple-group comparisons were performed with 1-way ANOVA followed by the Tukey posttest. The Kruskal and Wallis test followed by the Dunn test comparison of pairs was used to analyze data that did not show normal distribution. Values of P<0.05 were considered significant. All statistical analyses were performed with GraphPad Prism (version 6.01) software.
Results

Chronic HF Is Associated With Cardiac Recruitment of Activated/Effector T Cells
In a first set of experiments, we evaluated the expression profile of chemokines implicated in lymphocyte recruitment in cardiac tissue. [16] [17] [18] As shown in Figure 1A , the expression of the chemokines CX3CL1, CXCL16, and CXCL10 was significantly higher in ventricular tissues from mice with transverse aortic constriction (TAC)-induced HF than from sham-operated animals. We also observed a strong increase in the expression of CCL17, a chemokine associated with DC stimulation that is involved in the attraction of activated T cells. 19 To determine the presence of T cells in cardiac tissue, we performed immunofluorescence analysis. Our results indicated that HF is associated with infiltration of T cells into cardiac tissue ( Figure 1B and 1C ). To further characterize T-cell subtypes, we performed flow cytometry on the ventricular inflammatory cell fraction after 6 weeks of TAC (see the gating strategy in Figure I in the online-only Data Supplement). An augmentation of ventricular T cells was retrieved after TAC. Indeed, the number of CD4 + and CD8 + T cells was increased by 3.2-and 2.3-fold, respectively, compared with sham mice ( Figure 1D ). In immunofluorescence studies, we confirmed the predominance of infiltrated CD4 + over CD8 + T cells ( Figure 1D and Figure IIA and IIA in the online-only Data Supplement). To further assess the activation status of these cells, we examined the expression level of CD44 to discriminate activated/effector T cells from their naïve counterpart. Our results showed that the number of activated/effector CD4 + T cells (CD4 + CD44 hi ) increased in the heart after TAC ( Figure 1E ). Such an increase was not observed for CD8 + CD44 hi T cells (data not shown). Among inflammatory cells, we also observed an accumulation of antigen-presenting cells (identified as CD11c hi MHCII hi cells; Figure III in the online-only Data Supplement) within the failing heart.
Chronic HF Is Associated With Increased Cellularity of Mediastinal Draining Lymph Nodes and Th1 Polarization of T Cells
Draining lymph nodes, the epicenter of the immune responses, are dynamic lymphoid structures. At autopsy, we observed an enlargement of heart mediastinal draining lymph nodes (MLNs) associated with a strong increase in total cell number ( Figure 2A and 2B) in mice submitted to TAC. In addition, cells isolated from MLNs of TAC animals and stimulated ex vivo with anti-CD3ɛ anti-CD28 antibodies secreted a higher level of the T-cell growth factor IL-2 than cells isolated from sham animals ( Figure 2C ). Moreover, analysis by flow cytometry revealed an increase in CD4 + and CD8 + T cell numbers in MLNs after TAC compared with sham animals ( Figure 2D ; see the gating strategy in Figure IV in the onlineonly Data Supplement). These results support the enhanced T-cell proliferation in lymph nodes after TAC. Differences in lymphocyte subsets after TAC were not observed in spleen (data not shown).
To assess the potential difference in Th1/Th2 polarization, cells isolated from MLNs were stimulated ex vivo for 48 hours by anti-CD3ɛ anti-CD28 antibodies. MLN cells from the TAC group produced more interferon-γ, the Th1 cytokine, after TCR-dependent activation than cells from sham animals (sham, 13.05±3.01 ng/mL versus TAC, 58.95±10.4 ng/mL; P<0.01; Figure 2E ). In contrast, the level of the Th2 cytokine IL-4 was very low in sham animals and diminished after TAC ( Figure 2E ). These results were confirmed by intracellular staining and flow cytometry showing a higher number of interferon-γ-positive CD4 + and CD8 + T cells after TAC ( Figure 2F and Figure and unaffected by TAC. Taken together, these results suggest a preferential Th1-type polarization of MLN T cells.
Absence of B and T Lymphocytes Attenuates the Transition From Hypertrophy to HF
To determine whether mobilization of lymphocytes in cardiac tissue has an impact on the progression to HF, we submitted RAG2KO mice to TAC. RAG2 encodes the recombination activation gene 2, which catalyzes V(D)J recombination, an essential step in the generation of immunoglobulins and T lymphocyte receptors. As a consequence, RAG2KO mice are completely deficient in mature B and T lymphocytes. According to echocardiography parameters (Table 1) , left ventricular dimensions and function were similar in WT and RAG2KO mice under unstressed control conditions. After 6 weeks of TAC, the absence of lymphocyte prevented cardiac dilation but not ventricular hypertrophy and attenuated cardiac contractile dysfunction induced by pressure overload (Table 1 ). In addition, mRNA expression of the HF markers atrial and brain natriuretic factors was significantly lower in RAG2KO TAC compared with WT TAC mice ( Figure 3A ). HF was also associated with a decrease in sarco(endo)plasmic reticulum Ca 2+ ATPase (SERCA2a) expression and a main shift in the myosin heavy chain isoforms from α (MYH6) to β (MYH7). The decrease in mRNA expression of SERCA2a and MYH6 was attenuated in RAG2KO TAC compared with WT TAC mice ( Figure 3A ). These results indicate that the absence of B and T lymphocytes prevented cardiac dilation and attenuated cardiac dysfunction induced by TAC, suggesting a role of lymphocytes in the transition from hypertrophy to HF.
Reconstitution of T Lymphocytes Promotes Pressure Overload-Induced HF
To investigate the role of T cells in progression to HF, we transferred purified T cells from donor WT mice into RAG2KO mice. After T-cell reconstitution, RAG2KO+CD3 and RAG2KO mice injected with PBS (RAG2KO+PBS) were submitted to TAC. As expected, a strong infiltration of CD3 + T cells detected by immunofluorescence was retrieved in left ventricular tissue of RAG2KO+CD3 mice after TAC ( Figure 3B ). T-cell reconstitution in RAG2KO mice before surgery produced a significant decrease in cardiac contractility as revealed by reduced fractional shortening (FS) in RAG2KO+CD3 compared with control RAG2KO+PBS mice (FS: RAG2KO+PBS, 24.97±3.4% versus RAG2KO+CD3, 16.4±2.0%; P<0.05; Figure 3C and Figure Data Supplement). According to deterioration of contractile function, expression of the HF markers atrial and brain natriuretic factors was significantly increased in RAG2KO+CD3 compared with RAG2KO+PBS mice ( Figure 3D ). Taken together, these results show that T cells contribute to progression of HF after TAC.
T Lymphocytes Promote Fibrosis by Enhancing Collagen Accumulation and Cross-Linking After TAC
Macrophages are known to be involved in inflammatory and fibrotic processes. We observed that TAC-induced HF was associated with macrophage infiltration (identified as CD68 + cells; Figure 4A and 4B) and excessive perivascular and interstitial fibrosis in cardiac tissue of WT mice ( Figure 4C and 4D). In the absence of lymphocytes, both macrophage infiltration (WT TAC, 159±20 cells/mm 2 vs RAG2KO TAC, 97±12 cells/mm 2 ; P<0.05; Figure 4B ) and excessive fibrosis (WT TAC, 6.5±1.0% versus RAG2KO TAC, 2.2±0.6%; P<0.01; Figure 4D ) were prevented.
After T-cell replenishment, macrophage density (WT TAC, 159±20 cells/mm 2 ; RAG2KO+CD3, 154±13 cells/mm 2 ; Figure 4B ) and ventricular fibrosis measured in RAG2KO+CD3 (WT TAC, 6.5±1.0%; RAG2KO+CD3, 6.43%; Figure 4D ) were similar to those found in WT mice. These results support a role of T lymphocytes in deleterious cardiac remodeling seen after 6 weeks of TAC in WT animals.
To gain insight into the mechanisms responsible for the ventricular fibrotic response induced by T cells, we determined the levels of collagen deposition in cardiac tissue by picrosirius red staining. As shown in Figure 5A , RAG2KO mice submitted to TAC presented a significant decrease in collagen content compared with WT mice. In RAG2KO mice transferred with T lymphocytes, the amount of collagen was comparable to that observed in WT mice after TAC, supporting the involvement of these cells in promoting cardiac collagen accumulation ( Figure 5B ).
The mRNA expression of the 2 main procollagens Coll1a1 and Coll3a1 was upregulated after TAC to a similar extent in both the WT and RAG2KO groups ( Figure 5C ). In addition, T-cell transfer into RAG2KO mice did not significantly increase the expression of Coll1a1 and Coll3a1 mRNAs ( Figure 5D ). These results indicate that the profibrotic activity of T lymphocytes involves collagen accumulation by a mechanism independent of procollagen gene expression.
Dysregulation of both collagen deposition and assembling in cross-linked fibers, leading to cardiac fibrosis, is a major determinant of cardiac dysfunction. 20 Recently, Satoh et al 7 suggested that T cells might promote collagen fiber formation by stimulating lysyl oxidase (LOX), an enzyme responsible for collagen cross-linking. LOX is produced as an inactive proenzyme (50 kDa) that is cleaved in a shorter active form (32 kDa). In our study, we observed a strong increase in LOX mRNA expression in cardiac tissue of WT mice after TAC ( Figure 6A ). This phenomenon was associated with an enhanced amount of the pro-LOX and mature form of LOX, as determined by Western blot ( Figure 6B ). In cardiac tissue of RAG2KO TAC mice, the increase in LOX mRNA was significantly lower than that observed in WT animals after TAC ( Figure 6A ). In addition, although the amount of the pro-LOX protein was unchanged, the mature LOX was downregulated in RAG2KO after TAC compared with sham ( Figure 6C ). Reconstitution of T lymphocytes significantly increased LOX mRNA and protein expression in cardiac tissue after TAC, mimicking the changes observed in WT mice ( Figure 6A -6D).
To determine whether LOX modification subsequently affected cross-linked collagen density, we examined collagen fibrils by picrosirius red staining under polarized light. 21 Our results showed the presence of abundant birefringent fibers in WT mice after TAC. Collagen fibers, faintly detectable in RAG2KO mice, were strongly visible in T cell-reconstituted mice (RAG2KO+CD3; Figure 6E ). Overall, these results indicate that T cells participate in adverse cardiac remodeling after 
Lack of Functional CD4 + but Not CD8 + T Cells Prevented Cardiac Remodeling and Failure in Response to Pressure Overload
To define the specific contribution of T cell subsets in pressure overload-induced HF, we submitted mice lacking functional CD4 + T cells (MHCIIKO) and CD8 + T cells (CD8KO) to pressure overload. After TAC, MLNs isolated from MHCIIKO mice did not exhibit a size increase or higher cellularity compared with sham animals ( Figure VIIA Table 2 ). The downregulation of SERCA2a and MYH6 isoform genes, generally observed in HF after TAC, was absent in MHCIIKO mice ( Figure 7A ). In addition, the fact that the expression of atrial and brain natriuretic factors was less increased compared with WT TAC further supports the role of CD4 + T cells in promoting HF ( Figure 7A ). The absence of CD4 + T cells also prevented adverse remodeling, as seen by largely reduced fibrosis, collagen content, and macrophage infiltration after 6 weeks of TAC ( Figure 7B and 7C and Figure VIII in the online-only Data Supplement). In addition, the lack of CD4 + T cells significantly blunted upregulation of mRNA and protein expression of LOX and the subsequent A, Cardiac mRNA expression of atrial (ANF) and brain (BNF) natriuretic peptides, α-and β-myosin heavy chains (MYH6, MYH7), and the sarco(endo)plasmic reticulum Ca 2+ ATPase (SERCA2a) of wild-type (WT) mice and mice deficient for recombination activating gene 2 expression (RAG2KO) mice (n=10). mRNA expression was normalized to GAPDH and represented as fold change to WT sham. B, Immunofluorescence of the T-cell marker CD3 (red) and the pan-leukocyte marker CD45 (green) in cardiac tissue of RAG2KO mice reconstituted with CD3 (RAG2KO+CD3) after TAC. Merged image illustrate coexpression, and nuclei were stained by DAPI (blue). Figure 7D-7F ). Taken together, these results highlight that CD4 + T cells are required for the transition from hypertrophy to HF.
Next, we performed TAC in CD8KO mice to determine the role of CD8 + T cells in the progression of HF. At autopsy, TAC mice exhibited swollen MLNs with CD4 + T-cell density very similar to that observed in WT TAC ( Figure IXA and IXB in the online-only Data Supplement). Echocardiography showed that cardiac function was altered in CD8KO mice after TAC, as indicated by a dramatic decrease in the FS (FS: CD8KO sham, 37.87±1.53% versus CD8KO TAC, 20.63±2.76%; P<0.001; Figure 8A ) and the development of cardiac dilation (left ventricular internal dimension at diastole: CD8KO sham, 0.330±0.006 versus CD8KO TAC, 0.388±0.017; P<0.05; Figure 8A and Figure X in the online-only Data Supplement). TAC also modified the mRNA expression of atrial and brain natriuretic factors and SERCA2a compared with sham mice, confirming the severity of cardiac failure ( Figure XI Our results clearly showed that, unlike CD4 + T cells, CD8 + T cells are not required for developing chronic HF.
To further assess the implication of antigen recognition by the CD4 + T cells, we performed experiments on OT-II mice. After TAC, these mice did not develop cardiac dilation (left ventricular internal dimension at diastole: OT-II sham, 0.347±0.013 cm versus OT-II TAC, 0.360±0.019 cm; P=NS; Figure 8C and Figure IV in the online-only Data Supplement) and showed preserved cardiac function (FS: OT-II sham, 42.80±3.36% versus OT-II TAC, 35.25±3.77%; P=NS; Figure 8C and Figure IV in the online-only Data Supplement) and a reduced ventricular fibrosis (OT-II sham, 0.6±0.6% versus OT-II TAC, 1.8±0.4% P=NS; Figure 8D ). These findings suggest that deleterious effects of CD4 + T cells depend on antigen recognition.
Discussion
Using combined approaches in different mouse models, we demonstrated here the requirement of CD4 + T cells in the transition from compensated hypertrophy to HF.
Our results showed that end-stage HF was characterized by an accumulation of both CD4 + and CD8 + T cells in cardiac ventricles. In agreement with these results, overexpression of chemokines such as CX3CL1, CCL17, CXCL10, and CXCL16 involved in the recruitment and homing of T cells in injured tissues [16] [17] [18] 22 has also been observed during HF. The upregulation of CCL17, expressed mainly by activated DCs in various nonlymphoid organs, 19 was concomitant with higher cardiac infiltration of DCs in failing heart.
HF was also correlated with robust expansion of heart MLNs, an increased number of CD4 + and CD8 + T cells, and elevated secretion of the T-cell growth factor IL-2 after ex vivo TCR stimulation. These data support T-cell proliferation in MLNs during chronic HF. Cytokines production by MLN T cells assessed after anti-CD3ɛ/anti-CD28 stimulation revealed a significant increase in the Th1-type cytokine (interferon-γ) and a decrease in the Th2 type cytokine (IL-4) production in mice subjected to TAC. Intracellular staining uncovered the participation of both CD4 + and CD8 + T cells in interferon-γ production. These results are in agreement with observations made in clinical studies describing a positive correlation between T-cell polarization to Th1 and left ventricular dysfunction in patients with HF. 6, 23 To date, the relationship between T-cell activation and the development of chronic HF has been poorly defined.
In our present study, we evaluated the participation of T lymphocytes in cardiac remodeling and in transition from hypertrophy to HF by using lymphocyte-deficient mice as models. After TAC, hearts of RAG2KO mice did not undergo ventricular dilation, exhibited preserved contractile function, and showed a drastic reduction in fibrosis. Transfer of T lymphocytes, but not B lymphocytes (F.L., unpublished data), enhanced contractile dysfunction and promoted adverse ventricular remodeling in RAG2KO after TAC. Although infiltration of both CD4 + and CD8 + T cells was observed in failing hearts of WT animals, only the CD4 + T-cell subset plays a crucial role in cardiac dysfunction. Indeed, MHCIIKO mice lacking mature CD4 + T cells with normal CD8 + T-cell compartment 24 were preserved from ventricular dilation and contractile dysfunction and exhibited blunted ventricular fibrosis after TAC. In contrast, CD8KO mice developed cardiac failure and displayed adverse remodeling. Moreover, the fact that a higher number of CD8 + T cells was observed within cardiac tissue of MHCIIKO mice after TAC further argues against a role of this subset in the pathology ( Figure VIIA Our results also showed a striking effect of T cells in fibrotic response induced by pressure overload. Indeed, the significant increase in ventricular fibrosis and collagen deposition observed in WT mice after TAC was not retrieved in RAG2KO mice, which lack T cells. However, T-cell transfer induced a fibrotic response similar to that found in WT mice after TAC. This fibrotic process was not affected by the absence of CD8 + T cells but was prevented in mice lacking the CD4 + T-cell subset. The profibrotic activity of T lymphocytes appeared independent of procollagen gene expression because all groups of mice (WT, RAG2KO, RAG2KO+CD3, CD8KO, and MHCIIKO mice) exhibited similarly increased procollagen I and III mRNA after TAC.
Interestingly, the increase in fibrosis and collagen accumulation was concomitant with enhanced collagen fiber density observed in WT mice after TAC. The assembling into final collagen fibers is a process mediated by LOX enzymes. Moreover, the induction of LOX seems to be a general feature observed in a variety of fibrotic processes in different organs and interestingly has been reported in the fibrotic myocardium of patients with chronic HF. 25, 26 In WT mice, LOX expression and ventricular collagen fiber density were increased after TAC, whereas these effects were strongly reduced in MHCIIKO and RAG2KO mice. In addition, cardiac contractile dysfunction induced by the transfer of T cells into RAG2KO mice was accompanied by the upregulation of LOX expression and accumulation of collagen fibers in heart tissue. These results reveal a new contribution of T lymphocytes in fibrosis and collagen accumulation in chronic pressure overload. T cells also participate in cardiac collagen cross-linking through the induction of LOX expression. It is noteworthy that, in the case of acute cardiac injury, T lymphocytes seem to have a positive effect by improving wound healing of the myocardium and collagen maturation. 14 These results, along with ours, underline the relevance of T lymphocytes in fibrotic response that could be positive during cardiac repair after acute ischemia and negative during chronic pressure overload. Recently, numerous studies delineated strong implication of IL-17 and IL-1 T cell-secreted cytokines in cardiac fibrosis observed in autoimmune heart diseases. [27] [28] [29] The participation of these cytokines in pressure overload-induced HF deserves further investigation. The participation of immune system in cardiac remodeling is supported by previous reports describing the beneficial effect of immunomodulation in hypertensive remodeling. Indeed, sustained angiotensin II infusion in mice induced hypertrophic cardiac remodeling and increased the number of activated circulating CD4 + T subsets. Immunosuppressive treatment of mice by adoptive transfer of regulatory T cells has been shown to attenuate both angiotensin II-induced cardiac fibrosis and hypertrophy. 30 Regulatory T cells are a lineage of T cells with anti-inflammatory properties and suppressive effects on immune responses. 19 They also strongly reduced ventricular fibrosis with only a small effect on left ventricular hypertrophy in a mouse model of ventricular pressure overload. 31 In addition to these previous studies, our results showed that CD4 + T cells are required for adverse remodeling and HF. The preserved cardiac function of OT-II mice after TAC suggests that the deleterious effect of CD4 + T cells is mediated by an inappropriate recognition of antigen. Putative antigens triggering T-cell activation have been proposed in cardiac disease. 32 At present, the identity of antigens incriminated in the detrimental effects during pressure overload induced chronic HF remains to be defined.
Table 2. Absence of CD4 + T Cells in MHCIIKO Mice Prevents Cardiac Dilation and Dysfunction Induced by 6 Weeks of TAC
Conclusions
Our results support the concept that T cells, and more specifically the CD4 + T-cell subset, play a crucial role in pressure overload-induced cardiac remodeling leading to HF. These cells aggravate tissue remodeling and trigger the transition from compensated hypertrophy to HF. Intervention that modulates CD4 + T-cell activity might represent a novel therapeutic target for the treatment of HF.
CLINICAL PERSPECTIvE
Cardiac remodeling induced by pressure overload is a common precursor to heart failure in humans. Despite the widespread use of therapeutics, mortality and morbidity remain elevated in patients with heart failure, suggesting that pathological mechanisms are insufficiently affected by current treatments. In this study, we showed for the first time the critical role of the adaptive immune system in the onset of chronic heart failure. Indeed, using different models of immunodeficient mice, we demonstrated that the absence of T lymphocytes prevents the transition from cardiac hypertrophy to heart failure after ventricular pressure overload. In addition, we identified the CD4 + T-cell subsets as the major actor of the adverse ventricular remodeling. This maladaptive effect of CD4 + T cells involves a profibrotic process associated with collagen accumulation and maturation, leading to cardiac dysfunction. These data underline that adverse remodeling and evolution to heart failure are mediated by an inappropriate activation of immune system, probably triggered by neoantigen generation or by self-tolerance breakdown. These studies identify a previously undefined role for CD4 + T cells in pressure overload-induced cardiac remodeling and in the transition to heart failure. Prevention of deleterious T-cell activation may represent a new therapeutic approach to improve outcomes during pressure overload-induced heart failure in humans.
SUPPLEMENTAL MATERIAL
Supplemental Methods
Transverse aortic constriction
Mice were anesthetized with intraperitoneal ketamine (60 mg/kg) and xylazine (6 mg/kg). Anesthesia was maintained during chirurgical procedure with isoflurane (1.5%). Transverse aortic constriction (TAC) was performed as previously described. 1 
Echocardiography and hemodynamic measurements
Animals were anesthetized with 2% isoflurane and examined by trans-thoracic echocardiography (echocardiograph Vivid 7 ultrasound, GE) 6 weeks after surgery. Cardiac ventricular dimensions were measured on M-mode images as previously described. 1 The echocardiography operator was blinded to genotype and mice chirurgical procedure.
Real time PCR analysis
RNA was extracted using the Qiagen RNeasy Mini Kit from cardiac tissue according to the manufacturer's instructions. DNase treatment was systematically performed. Quality and quantification of extracted RNA were assessed by Experion analysis. The cDNA was synthesized using Superscript The antibodies used for histology staining were as follows: anti-CD68 (clone FA-11, AbD serotec) and
anti-CD3e (clone 145-2C11, AbD serotec).
Immunofluorescence
Cryosections of 5µm were blocked using the Avidin/Biotin blocking kit (Vector Labs) followed by 2% normal goat serum (Sigma-Aldrich) and 1% BSA in PBS. Sections were stained overnight with rat antimouse CD45 (clone 30-F11, BD Pharmingen), CD4 (clone GK 1.5, eBioscience) or CD8α (clone 53-6.7, eBioscience) and hamster anti-mouse CD3 followed by staining with secondary antibody: anti-rat DL488 and anti-hamster-Biotin/Streptavidin DL549. Nuclei were stained by DAPI.
Histological Staining Methods
Cryosections of 10µm were stained with Masson's trichrome and picrosirius red in order to assess cardiac fibrosis and collagen content. Three sections per heart were stained and digitized with a Hamamatsu NanoZoomer. Finally, stained areas and total surface from each section were determined using color-based thresholding and quantified by ImageJ software. To assess collagen fibers, picrosirius red stained sections were studied under polarized light.
Reconstitution of T cell populations into RAG2KO recipient mice before TAC
Spleens of control WT mice were flushed with cold PBS and erythrocytes were eliminated using ACK lysis buffer. Splenic CD3 + T cells were isolated by immunomagnetic selection (EasySep CD3-negative selection kit, StemCell Technologies). T cell purity was routinely greater than 90%. RAG2KO recipient mice were injected with T cells (2x10 7 cells in a volume of 250 μl) or PBS into the left external jugular vein. Two weeks after injection, RAG2KO+CD3 and control RAG2KO+PBS mice underwent TAC.
Ex vivo re-stimulation of T cells
For cytokine production measurements, 5×10 5 mediastinal lymph nodes cells were stimulated in 500µl
RPMI supplemented with 5% FBS, non essential amino acid and 50µM β-mercaptoethanol per well in 48-well plates. T cells were stimulated with 1.5 µg/ml of anti-CD3 and anti-CD28 mAb (BioLegend).
Levels of IL-2 were evaluated after 12h and levels of IL-4 and IFNγ after 48h, using enzyme-linked immunosorbent assay (ELISA, eBioscience) kits according to the manufacter's instructions. The absorbance was measured at 450 and 570 nm.
Intracellular cytokine assay
Mediastinal lymph nodes cells (2x10 6 /ml) were resuspended in RPMI supplemented with 5% FBS, non essential amino acid and 50μM β-mercaptoethanol per well in 24-well low-adherence plates. Cells were stimulated with phorbol ester (PMA 50 ng/ml) and calcium ionophore (ionomycin 1 μg/ml) for 4 hours. Brefeldin A was added during the last 2 hours (10 μg/ml). Cells were stained for surface expression, fixed, and permeabilized using Cytofix/Cytoperm kit (BD Biosciences) and stained for intracellular IFNγ and IL-4 before analysis on LSRII.
Isolation of cardiac immune cells
The hearts were cut into pieces and digested in RPMI containing 0.12 mg/ml of Liberase TM (Roche) for 10 min at 37°C with vigorous stirring. The supernatant was then added to 10 ml of ice-cold RPMI supplemented with 10% of heart inactivated fetal bovine serum (FBS). Two milliliters of fresh digesting solution was added to the remaining tissue fragments. Cell suspensions were pooled and erythrocytes were lysed by using ACK lysis buffer. Cell suspensions were stained for flow cytometry analysis.
Flow cytometry
Spleens were flushed and crushed in cold PBS and erythrocytes were removed by using ACK lysis buffer. Then, spleen, lymph node and cardiac cell suspensions were passed through a 40µm strainer.
Fc receptors were blocked with 5 μg/ml of anti-mouse CD16/CD32 in PBS containing 4% FBS and 2mM EDTA for 20 min at 4°C. Cells were stained with mixtures of antibodies for 30 min at 4°C then incubated with Live/dead Yellow fluorescent reactive dye (Invitrogen) dead staining kit accordingly to the manufacturer's instruction before fixation with PFA (1%). Cardiac cell numbers were quantified using CountBright absolute counting beads (Life Technologies). Prior to acquisition, cells were resuspended in PBS/FBS/EDTA solution. For cardiac cell suspensions, 52 000 beads were added in each cardiac cell samples before acquisition. Flow cytometric multiparameter acquisition was
